In 2013, R&D related to eye conditions were the most attractive to venture capitals (VC). They supported this research area with$0.86billion

In 2013, R&D related to eye conditions were the most attractive to venture capitals (VC). Theysupported this research area with$0.86billion.Other importantmedical sectors for VC's were endocrine glands and pancreas ($0.73 billion), research on brain ($0.66 billion) and research on heart ($0.66 billion)...

more http://cebiotech.com

 

By David Gamero Ledo, Elżbieta Świętek & Klaudia Polakowska, Centre for Innovation, Technology Transfer and University Development, Jagiellonian University